Cost-effectiveness of antiviral therapy in treatment-naive patients with chronic hepatitis C (genotype 1)

Interferon-free therapy for genotype 1 hepatitis C are preferable from the point of view of clinical effectiveness and safety.The purpose of work was the assessment of costs and costeffectiveness of regimens for the treatment of HCV (1 genotype) at the treatment-naive patients.Methods. The assessmen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: A. V. Rudakova, D. A. Gusev, A. N. Uskov, L. N. Konovalova, Yu. V. Lobzin
Format: Artigo
Sprache:Russo
Veröffentlicht: Journal Infectology 2017-06-01
Schriftenreihe:Žurnal Infektologii
Schlagworte:
chronic hepatitis c
genotype 1
naive patients
direct acting antivirals
cost-effectiveness
Online Zugang:https://journal.niidi.ru/jofin/article/view/607
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge